Nodular regenerative hyperplasia (NRH) of the liver usually occurs in patients with rheumatological and myelolymphoproliferative disorders; the occurrence post-liver transplantation (LT) has traditionally been ascribed to the use of azathioprine. We report the clinical, biochemical, and radiological
The significance of nodular regenerative hyperplasia in the transplanted liver
β Scribed by Alyssa Krasinskas
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 55 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.21276
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Nodular regenerative hyperplasia (NRH) of the liver is a condition of unknown origin, rarely occurring in children, usually accidentally discovered, described in association with a variety of clinical conditions and drugs. Confusion with other types of hepatic masses may pose a problem and for this
editor, indicating topics they would like to comment on. They are welcome to telephone (203/785-7169 or 203/932-5711) to express their willingness to contribute, to indicate a specific article they think worthy of comment or to identify potential authors of future HE-PATOLOGY Elsewhere commentaries.
Nodular regenerative hyperplasia is one of the causes of noncirrhotic portal hypertension and has recently been described in human immunodeficiency virus-infected patients, and the potential role of a prothrombotic state and hepatotoxic antiretroviral medication has been suggested. Moreover, it is n